Skip to main content

Table 1 The characteristics of patients, surgery, and anesthesia

From: Effects of ramosetron orally disintegrating tablets on the prophylaxis of post-discharge nausea and/or vomiting in female patients undergoing day surgery under general anesthesia: a randomized controlled trial

  Control (n = 67) Ramosetron (n = 67) P
Age (years) 39 (8) 40 (8) 0.344
Weight (kg) 61 (14) 58 (11) 0.257
Height (cm) 160 (5) 160 (5) 0.995
BMI (kg/m2) 23 (5) 22 (4) 0.175
ASA   0.136
 1 42 (63%) 50 (75%)  
 2 25 (37%) 17 (25%)
Anesthesia time (min) 52 (23) 48 (21) 0.219
Surgery time (min) 27(19) 23 (17) 0.198
Previous PONV 1 (1%) 3 (4%) 0.619
Smoking 2 (3%) 4 (6%) 0.680
Types of surgery   0.587
 Gynecology 52 (78%) 45 (67%)  
 ENT 7 (10%) 9 (14%)
 Breast 3 (5%) 5 (7%)
 Orthopedics 2 (3%) 5 (7%)
 Dental 2 (3%) 3 (5%)
 Urology 1 (1%) 0 (0%)
  1. Data are expressed as mean (SD) or number of the patients (proportion)
  2. BMI body mass index, ASA American Society of Anesthesiologists, PONV postoperative nausea and vomiting, ENT ear, nose, and throat